High-dose n-3 fatty acid treatment in non-alcoholic fatty liver disease is independently associated with reduced hepatic steatosis and improved hepatic insulin sensitivity

LS Bhatia; E Scorletti; F Shojaee-Moradie; M Umpleby; GF Clough; NP Curzen; PC Calder; CD Byrne

Back

High-dose n-3 fatty acid treatment in non-alcoholic fatty liver disease is independently associated with reduced hepatic steatosis and improved hepatic insulin sensitivity

Conference presentation

Peer reviewed

High-dose n-3 fatty acid treatment in non-alcoholic fatty liver disease is independently associated with reduced hepatic steatosis and improved hepatic insulin sensitivity

LS Bhatia, E Scorletti, F Shojaee-Moradie, M Umpleby, GF Clough, NP Curzen, PC Calder and CD Byrne

DIABETIC MEDICINE, Vol.31, pp.53-53

01/03/2014

Abstract

Science & Technology

Life Sciences & Biomedicine

Endocrinology & Metabolism

ENDOCRINOLOGY & METABOLISM

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333445900139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

31 Record Views

Details

Title: High-dose n-3 fatty acid treatment in non-alcoholic fatty liver disease is independently associated with reduced hepatic steatosis and improved hepatic insulin sensitivity
Creators: LS Bhatia
E Scorletti
F Shojaee-Moradie
M Umpleby
GF Clough
NP Curzen
PC Calder
CD Byrne
Contributors: WILEY-BLACKWELL (Publisher)
Publication Details: DIABETIC MEDICINE, Vol.31, pp.53-53
Date published: 01/03/2014
Date submitted: 17/05/2017
Identifiers: 99512978902346
Academic Unit: University of Surrey
Resource Type: Conference presentation

High-dose n-3 fatty acid treatment in non-alcoholic fatty liver disease is independently associated with reduced hepatic steatosis and improved hepatic insulin sensitivity

Abstract

Files and links (1)

Metrics

Details

Usage Policy